𝔖 Bobbio Scriptorium
✦   LIBER   ✦

AOSOP6 Results from the 2-year open-label extension treatment phase of a pivotal phase 3 study of denosumab in patients with breast cancer and bone metastases previously treated with zoledronic acid or denosumab

✍ Scribed by A.T. Stopeck; A. Lipton; M. Martín; J-J. Body; A. Paterson; G.G. Steger; K. Tonkin; R.H. de Boer; Y. Fujiwara; D. Yardley; J. Jassem; T. Takano; P. Solal-Céligny; M. Fan; A. Braun


Book ID
116431039
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
42 KB
Volume
48
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES